| Components of Outpatient Child and Youth Concurrent Disorders Programs: A Critical Interpretive Synthesis: Composantes des programmes de troubles concomitants des enfants et … T Rosic, E Lovell, H MacMillan, Z Samaan, RL Morgan The Canadian Journal of Psychiatry 69 (6), 381-394, 2024 | | 2024 |
| Substance Use Disorders J DeVido, CH Hirsch, N Sanger, T Rosic, Z Samaan, JA Bourgeois Geriatric Psychiatry: A Case-Based Textbook, 379-406, 2024 | | 2024 |
| Principles for Primary Care Screening in the Context of Population Health KJ Kelleher, W Gardner, AR Kemper, L Chavez, K Pajer, T Rosic Academic Pediatrics, 2024 | | 2024 |
| Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol LD Harrison, AY Dumicho, AB Eddeen, P Tanuseputro, CE Kendall, ... Academic emergency medicine 31 (3), 220-229, 2024 | | 2024 |
| Components of Outpatient Child and Youth Concurrent Disorders Programs: A Critical Interpretive Synthesis. T Rosic, E Lovell, H Macmillan, Z Samaan, RL Morgan Canadian Journal of psychiatry. Revue Canadienne de Psychiatrie …, 2023 | | 2023 |
| Trends in rates of opioid agonist treatment and opioid-related deaths for youths in Ontario, Canada, 2013-2021 T Rosic, G Kolla, P Leece, S Kitchen, T Gomes JAMA Network Open 6 (7), e2321947-e2321947, 2023 | 5 | 2023 |
| Trends in office-based anxiety treatment among US children, youth, and young adults: 2006–2018 LJ Chavez, W Gardner, D Tyson, K Pajer, T Rosic, AR Kemper, K Kelleher Pediatrics 152 (1), e2022059416, 2023 | 1 | 2023 |
| Psychiatric Comorbidity in Patients with Opioid Use Disorder T Rosic | | 2023 |
| Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data L Naji, T Rosic, N Sanger, B Dennis, A Hillmer, J Hudson, A Worster, ... Frontiers in Psychiatry 13, 1046649, 2022 | 2 | 2022 |
| From the Ground up: Building Blocks of Outpatient Concurrent Mental Health and Substance Use Programs for Children and Youth T Rosic, E Lovell, G Conrad, T Moran, S Ling AACAP/CACAP 2022 Annual Meeting, 2022 | | 2022 |
| The inclusion of patients’ reported outcomes to inform treatment effectiveness measures in opioid use disorder. A systematic review N Sanger, B Panesar, M Dennis, T Rosic, M Rodrigues, E Lovell, S Yang, ... Patient Related Outcome Measures, 113-130, 2022 | 9 | 2022 |
| Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: A systematic review and meta-analysis L Naji, B Dennis, T Rosic, W Wiercioch, J Paul, A Worster, L Thabane, ... Drug and Alcohol Dependence 232, 109295, 2022 | 21 | 2022 |
| Factors associated with increased opioid use during the COVID-19 pandemic: A prospective study of patients enrolled in opioid agonist treatment T Rosic, L Naji, N Sanger, DC Marsh, A Worster, L Thabane, Z Samaan Journal of addiction medicine, 2022 | 7 | 2022 |
| Virtual psychiatric care fast-tracked: reflections inspired by the COVID-19 pandemic T Rosic, S Lubert, Z Samaan BJPsych bulletin 46 (1), 33-36, 2022 | 14 | 2022 |
| Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review EA van Reekum, T Rosic, A Sergeant, N Sanger, M Rodrigues, ... Journal of Medical Case Reports 15, 1-12, 2021 | 9 | 2021 |
| Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder K Leung, E Xu, T Rosic, A Worster, L Thabane, Z Samaan BMC psychiatry 21, 1-8, 2021 | 6 | 2021 |
| Cannabis use in patients treated for opioid use disorder pre-and post-recreational cannabis legalization in Canada T Rosic, N Sanger, B Panesar, G Foster, DC Marsh, L Rieb, L Thabane, ... Substance abuse treatment, prevention, and policy 16, 1-11, 2021 | 8 | 2021 |
| The association between cannabis use and outcome in pharmacological treatment for opioid use disorder T Rosic, R Kapoor, B Panesar, L Naji, DB Chai, N Sanger, DC Marsh, ... Harm reduction journal 18, 1-9, 2021 | 24 | 2021 |
| Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk? VYO Au, T Rosic, N Sanger, A Hillmer, C Chawar, A Worster, DC Marsh, ... Harm Reduction Journal 18, 1-10, 2021 | 16 | 2021 |
| 43.2 Youth Receiving Opioid Agonist Treatment: Exploring Differences and Similarities to Adult Patients in a Canadian Study T Rosic, Z Samaan Journal of the American Academy of Child & Adolescent Psychiatry 60 (10), S232, 2021 | 1 | 2021 |
